Strides Arcolab receives USFDA approval for Methoxsalen Softgel Capsules

06 Jun 2014 Evaluate

Strides Arcolab has received approval from the United States Food & Drug Administration (USFDA) for Methoxsalen Capsules USP, 10 mg (Soft Gelatin Capsules). According to IMS data, the US market for generic Methoxsalen Capsule is approximately $13.6 Million, with no generic player. The product will be manufactured at the Company's USFDA approved Oral dosage facility at Bangalore and marketed directly by Strides in the US Market.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

903.20 -6.55 (-0.72%)
31-Dec-2025 10:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.60
Dr. Reddys Lab 1261.45
Cipla 1492.85
Zydus Lifesciences 909.00
Lupin 2080.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×